Curanex Pharmaceuticals Common Stock
CURX | NASDAQ
$5.29
+$0.35 (+7.09%)
At close: Oct 30, 2026, 3:59 PM ET
$5.10
-$0.19 (-3.63%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
Market Data
Market Cap $8.3M
Enterprise Value $5.63M
Beta -2.57
Average Volume 16.82K
Shares Outstanding (Diluted) 1.42M
Shares Change YoY 2.22%
Institutional Ownership 1.18%
Exchange NASDAQ
ISIN US23126K3041
Price Performance
Price Change 1M 5.2%
Price Change 3M 29.0%
Price Change 6M -28.5%
Price Change YTD -20.0%
Price Change 1Y -61.0%
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 17.3%
1Y CAGR (ann.) -63.9%
5Y CAGR (ann.) N/A
All-Time CAGR -90.3%
Valuation
PE Ratio -0.72
Forward PE N/A
PEG Ratio 0.01
Forward PEG 0.01
PS Ratio N/A
Forward PS N/A
PB Ratio 1.73
P/FCF Ratio -0.69
P/Adj. FCF Ratio -0.69
P/OCF Ratio -0.62
EV/Sales N/A
EV/EBIT -0.54
EV/EBITDA -0.54
EV/FCF -0.47
Earnings Yield -139.5%
FCF Yield -145.6%
Adj. FCF Yield -145.7%
Financial Health
Net Cash $2.66M
Total Debt $276.36K
Cash & Short-Term Investments $2.94M
Total Assets $5.07M
Current Ratio 45.95
Quick Ratio 45.95
Debt / Equity Ratio 0.06
Debt / EBITDA -0.03
Debt / FCF -0.02
OCF / Debt -43.71
Interest Coverage -2,580.17
Altman Z-Score 8.12
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -0.1%
Returns
Return on Assets -206.3%
Return on Equity -109.1%
Return on Invested Capital -208.4%
Return on Capital Employed -212.3%
Return on Tangible Assets -206.3%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -136.7%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y N/A
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 14, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-12.08M
Free Cash Flow $-12.08M
Adj. Free Cash Flow $-12.09M
FCF Per Share -$8.52
OCF Per Share -$8.52
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-69.34K
Operating Income $-10.55M
EBITDA $-10.43M
Net Income $-10.47M
EPS (Diluted) -$7.38
Revenue / Employee N/A
Profit / Employee $-1.74M
Employees 6
Add to Watchlist
Select watchlists to add or remove CURX